[
    "{\"step_by_step_thinking\": \"Enlimomab is an antibody that was tested for its potential to improve stroke outcomes. However, clinical trials showed that it did not improve outcomes and, in fact, might have worsened them. Therefore, it is not considered a viable treatment for improving stroke outcomes.\", \"answer_choice\": \"B\"}"
]